This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Exchange-Traded Notes: VIX vs. VXX

The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage.

By David Gillie

NEW YORK ( ETF Digest) -- With the explosion of ETFs (Exchange-Traded Funds) as trading mechanisms, it's no wonder that ETFs would develop into the realms of the absurd.

Like a bad spin-off from a '70s sitcom, ETFs spun off into ETNs (Exchange-Traded Notes). The difference between the two is radical.

An ETF value is based on the price of its underlying holdings (like a mutual fund). The capital of the fund is secured by the value of the stocks held in the fund. An ETN is an unsecured, unsubordinated debt security with significant basis on the credit rating of the issuer. Although ETNs may be named to indicate tracking certain futures markets or indices, due to the fact that their holdings are credit notes rather than tangible assets, such as ETFs, their price becomes largely supply and demand based rather than based on underlying holdings. ETNs were originally developed to function in bond markets similarly to ETFs in equities markets. Presumably that should work because a bond, although a credit instrument, has an actual tangible monetary value.

Where ETNs went haywire was attempting to track indices not based on a monetary value. The Volatility Index (VIX) is a classic example. The VIX is a measure of options contracts traded on the S&P 500 over a 30-day period. It has no monetary value. It would be like trying to assign a dollar value to the numbers on a thermometer.

Case in point: as of Thursday, the VIX is rising. At the same time (TVIX), supposedly a 2x leveraged ETN tracking the VIX, is in a total collapse. Therefore, it has little correlation to the index it is associated with, and selling (loss of demand) is driving the price dramatically lower. Meanwhile, another 2x leveraged issue (UVXY) associated to the VIX is having a dramatic rise -- a pure supply and demand circumstance with virtually no underlying basis of value.

The highest volume ETN associated to the VIX is iPath S&P 500 Short Term Futures (VXX). An overlay of VXX on the VIX chart clearly demonstrated VXX does not track the VIX, but rather follows by supply and demand.


The VXX (purple line) doesn't even remotely track the Volatility Index (blue line).

The August 2011 selloff triggered a dramatic spike on the VIX, yet VXX didn't reach its high until three months later. At that high on VXX, the VIX was achieving a lower high. Over the past week at the right of the chart, we see a complete divergence when the VIX was rising and VXX was falling.

This morning, after an overnight selloff and a declining market, traders discovered that TVIX is worthless and panic sell is setting in. VXX is struggling to keep some semblance to association with the VIX, but a distrustful bleed over from TVIX could put VXX (and even other ETNs) in a precarious position on these supply and demand based issues.

Exercise extra caution when considering a non-monetary based ETN.

Disclosure: At the time I writing, I own a position in TVIX.

Follow my intraday market commentary and various other observances on 
Facebook and  Twitter

This commentary comes from an independent investor or market observer as part of TheStreet guest contributor program. The views expressed are those of the author and do not necessarily represent the views of TheStreet or its management.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs